Answers are grounded in this paper and cite their sources.
Findings reveal reduced metastasis in canine cutaneous lymphoma with knockout of chemokine receptors, suggesting key roles in tumor growth.
Canine epitheliotropic cutaneous T-cell lymphoma (ECTCL) is a malignant neoplasm exhibiting various skin lesions. Metastasis to the lymph nodes and distant organs contributes to the poor prognosis of ECTCL; however, the underlying molecular mechanisms remain unclear. In the present study, the roles of chemokine receptors, such as CC chemokine receptor (CCR) 4 and CCR7, in the migration of tumor cells were examined using a canine cutaneous lymphoma model. Three mouse groups were prepared and xenografted with wild-type (WT), CCR4 knockout (KO), or CCR7KO canine ECTCL (EO-1) cells. The proportion of EO-1 cells in tissues and blood was significantly lower in the CCR4KO and CCR7KO groups than in the WT group. Only the iliac lymph node, a sentinel lymph node for the xenograft site, was enlarged with the infiltration of EO-1 cells in all groups. The size of the iliac lymph node was smaller in the KO groups than in the WT group. All mice developed a subcutaneous nodule at the xenograft site, which was smaller in the KO groups. In the cell proliferation assay, chemokine ligands stimulated an increase in EO-1 cells in the WT group, but not in the KO groups. These results suggest that CCR4 or CCR7 plays a vital role in the initial migration to sentinel lymph nodes and proliferation in a canine cutaneous lymphoma model.
No takes yet. Share an insight, caveat, or question.
Kanei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: